RevelAi Health and Zimmer Biomet Holdings have entered into a multi-year co-marketing agreement to commercialize generative AI-powered engagement solutions that advance value-based orthopedic care and health equity. This partnership aims to leverage AI-driven clinical workflows to reduce clinician burnout and address socio-demographic disparities in healthcare. RevelAi Health’s patient care-management platform and care team dashboard for providers will be commercialized by Zimmer Biomet, with the goal of delivering personalized, timely, and effective patient care. This collaboration has the potential to drive equitable value-based outcomes and ensure that every patient receives the care they deserve.
The partnership is significant, as it combines Zimmer Biomet’s innovative technologies with RevelAi Health’s cutting-edge generative AI population health solutions. This union can help address the needs of underserved and vulnerable populations, while optimizing value-based outcomes for clinicians. The use of AI-powered technology can streamline care workflows, enhance patient engagement, and reduce clinician burnout. It’s a step in the right direction towards achieving health equity and delivering high-quality patient care.
